These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 18342786

  • 1. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.
    Schmid I, Stachel D, Pagel P, Albert MH.
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):438-44. PubMed ID: 18342786
    [Abstract] [Full Text] [Related]

  • 2. Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children.
    Nishio N, Yagasaki H, Takahashi Y, Hama A, Muramatsu H, Tanaka M, Yoshida N, Yoshimi A, Kudo K, Ito M, Kojima S.
    Pediatr Transplant; 2009 Nov; 13(7):831-7. PubMed ID: 19067915
    [Abstract] [Full Text] [Related]

  • 3. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Akasheh M, Eastwood D, Vesole DH.
    Bone Marrow Transplant; 2003 Jan; 31(2):113-6. PubMed ID: 12621492
    [Abstract] [Full Text] [Related]

  • 4. Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival.
    Gorak E, Geller N, Srinivasan R, Espinoza-Delgado I, Donohue T, Barrett AJ, Suffredini A, Childs R.
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):542-50. PubMed ID: 15983554
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

  • 6. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
    Diaz MA, Vicent MG, Prudencio M, Rodriguez F, Marin C, Serrano A, Sevilla J, Casado J, Madero L.
    Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
    [Abstract] [Full Text] [Related]

  • 7. Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation.
    Madero L, Vicent MG, Sevilla J, Prudencio M, Rodríguez F, Díaz MA.
    Bone Marrow Transplant; 2002 Sep; 30(6):355-8. PubMed ID: 12235519
    [Abstract] [Full Text] [Related]

  • 8. Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome.
    Koreth J, Biernacki M, Aldridge J, Kim HT, Alyea EP, Armand P, Cutler C, Ho VT, Wu CJ, Antin JH, Soiffer RJ.
    Biol Blood Marrow Transplant; 2011 Mar; 17(3):421-8. PubMed ID: 20870027
    [Abstract] [Full Text] [Related]

  • 9. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
    Schneider DT, Lemburg P, Sprock I, Heying R, Göbel U, Nürnberger W.
    Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
    [Abstract] [Full Text] [Related]

  • 10. Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria.
    Maiolino A, Biasoli I, Lima J, Portugal AC, Pulcheri W, Nucci M.
    Bone Marrow Transplant; 2003 Mar; 31(5):393-7. PubMed ID: 12634731
    [Abstract] [Full Text] [Related]

  • 11. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
    Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F, Nysom K, Galambrun C, Fagioli F, Varotto S, Messina C, Verdeguer A, Urban C, Faraci M, Dini G, Fedeli S, Tichelli A, Rovelli A, Socié G.
    Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396
    [Abstract] [Full Text] [Related]

  • 12. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
    Bradley MB, Satwani P, Baldinger L, Morris E, van de Ven C, Del Toro G, Garvin J, George D, Bhatia M, Roman E, Baxter-Lowe LA, Schwartz J, Qualter E, Hawks R, Wolownik K, Foley S, Militano O, Leclere J, Cheung YK, Cairo MS.
    Bone Marrow Transplant; 2007 Oct; 40(7):621-31. PubMed ID: 17660841
    [Abstract] [Full Text] [Related]

  • 13. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 15. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Sohn SK, Kim DH, Baek JH, Kim JG, Lee KB, Lee KH, Lee JH, Choi SJ, Lee JH, Shin IH.
    Bone Marrow Transplant; 2006 Apr; 37(7):699-708. PubMed ID: 16501588
    [Abstract] [Full Text] [Related]

  • 16. Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders.
    Bittencourt H, Rocha V, Filion A, Ionescu I, Herr AL, Garnier F, Ades L, Esperou H, Devergie A, Ribaud P, Socie G, Gluckman E.
    Bone Marrow Transplant; 2005 Sep; 36(5):431-5. PubMed ID: 15980881
    [Abstract] [Full Text] [Related]

  • 17. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F, Diyachenko G, Zabelina T, Panse J, Wolschke C, Eiermann T, Binder T, Fehse B, Erttmann R, Kabisch H, Bacher U, Kröger N, Zander AR.
    Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
    Pavletic SZ, Smith LM, Bishop MR, Lynch JC, Tarantolo SR, Vose JM, Bierman PJ, Hadi A, Armitage JO, Kessinger A.
    Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
    [Abstract] [Full Text] [Related]

  • 19. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
    Zhu KE, Hu JY, Zhang T, Chen J, Zhong J, Lu YH.
    Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
    [Abstract] [Full Text] [Related]

  • 20. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
    Avetisyan G, Mattsson J, Sparrelid E, Ljungman P.
    Transplantation; 2009 Nov 27; 88(10):1222-6. PubMed ID: 19935377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.